Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
This article reviews the accumulated evidence on the role of cetuximab in HNSCC in the past decade, offering an overview of its current impact in the treatment of LA and R/M-HNSCC disease and its potential use in the era of immunotherapy.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | Erbitux | Genital Warts | HNSCC | Human Papillomavirus (HPV) | Immunotherapy | Oropharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study